. However, for most people diagnosed at the advanced stage, no effective therapeutic options are available because of its resistance and deleterious effects to chemotherapy and radiotherapy. Hence, a novel candidate selectively targeting carcinoma cells without compromising normal function is always the subject of investigation.
Esculetin (6,7-dihydroxycoumarin) is a coumarin derivative extracted from natural plants, such as Artemesia scoparia (Redstem Wormwood), Artemesia capillaris (Capillary Wormwood), and Ceratostigma willmottianum (Chinese Plumbago), and in the leaves of Citrus limonia (Chinese lemon) (Chang et al. 1996; Wang et al. 2002) , that has been commonly used as a folk medicine. Esculetin has been reported to have various pharmacological and biochemical activities including anti-oxidant, anti-inflammatory and anti-proliferative and anti-obesity activity (Jeon et al. 2015; Karmase et al. 2013; Kim et al. 2008; Sulakhiya et al. 2016 ). These beneficial pharmacological and biochemical activities confer esculetin a potential therapeutic role in allergic asthma (Hongyan 2016) , obesity (Yang et al. 2006) , depression ) and diabetes (Prabakaran and Ashokkumar 2013) .
Although some herbal products have shown hepatotoxicity (Tarantino et al. 2009 ), more and more studies have focused on the anti-cancer activity of esculetin. These studies demonstrated that esculetin could induce the apoptosis of cancer cells, including human gastric carcinoma, colorectal cancer, malignant melanoma as well as breast carcinoma Kim et al. 2015; Pan et al. 2015) . The underlying mechanisms are involved in reactive oxygen species-mediated D r a f t mitochondrial pathway and multiple signaling pathway et al. In addition, combination of esculetin with taxol could result in a further enhancement of apoptosis in human hepatoma HepG2 cells as compared to the treatment with taxol alone (Kuo et al. 2006) . All these rusults suggested that esculetin has therapeutic potential for the treatment of human malignancies.
Insulin-like growth factor (IGF) axis plays a pivotal role in the development of normal cell growth and differentiation as well as progression of various cancers (Ali et al. 2014; Daqian et al. 2015; Durzynska 2014; Lindsey and Mohan 2016) . It has been reported that IGF-1R knockout mice have only 50% body size as compared to the normal control mice (Baserga et al. 2003; Hartog et al. 2007 ). On the contrary, high circulating levels of IGF-1 are associated with increased risk of different types of cancers, largely depending on activation of the downstream cascade of the IGF axis (Sharon et al. 2015; Teng et al. 2016) . After binding to IGF-1R, IGF-1 phosphorylates the downstream substrates, resulting in activation of the phosphatidylinositide 3-kinase/Akt (PI3K/Akt) and mitogen-activated protein kinase (MAPK) signaling cascades (Kong et al. 2016; Zhou et al. 2016) . The over activation of PI3K/Akt and MAPK/ERK signaling pathways play a important role in increasing tumorigenesis, metastasis, and resistance to existing forms of cancer treatment through extensively phosphorylating apoptotic effector molecules, subsequently leading to cell proliferation and antiapoptosis (Appleman et al. 2012; Ju et al. 2015; ).
According to Jeon's report, the anti-proliferative effects of esculetin on oral squamous cell carcinoma were related to the inactivation of PI3K/Akt signaling pathway (Jeon D r a f t et al. 2016) . Our previous study indicated that esculetin could induce the apoptosis of hepatic carcinoma cells (Wang et al. 2015) , but the mechanism by which esculetin is involved in the cross-link between the IGF-1/PI3K/Akt signaling pathway and mitochondrial function regulation is not well understood.
The findings of the present study demonstrate that esculetin suppresses the growth of human hepatic cancer SMMC-7721 cells, which might be related to the IGF-1 mediated mitochondrial dysfunction caused by the inactivation of the PI3K/Akt signaling pathway.
Material and methods

Materials
Esculetin was obtained from Nanjin Jingzhu Biotechnology Company (purity>98%; Nanjing, China); 3-(4,5-dimethylthiazol)-2,5-diphenyltetrazolium bromide (MTT) were obtained from Amresco (USA); The Annexin V-FITC apoptosis detection kit, DAPI and caspase-3/-9 were purchased from Beyotime Institute of Biotechnology; Antibodies specific for IGF-1 Bcl-2, Bax, PI3K, Akt, cytochrome c were purchased from abcam Technology; Antibodies specific for β-actin, GAPDH and VDAC were purchased from proteintech; IGF-1 and LY294002 were purchased from sigma company; RPMI 1640 medium and calf serum were purchased from Gibco.
Cell lines and cell culture
The human hepatic cancer SMMC-7721 cells were obtained from Type Culture Collection of the Chinese Academy of Sciences (Shanghai, China). Cells were D r a f t cultured in RPMI 1640 medium containing 10% fetal calf serum, 100 units/ml streptomycin, and 100 units/ml penicillin, in a humidified cell incubator at 37 °C with an atmosphere of 5% CO 2 .
Cell viability assay SMMC-7721 cell viability was measured by the MTT method. Briefly, SMMC-7721 cells were seeded in 96-well plates at a density of 1.0×10 5 cells/ml and cultured for 24h, then treated with 0, 25, 50, 100, 200 or 300µg/mL esculetin followed by incubation at 37°C for 24h. Thereafter, MTT was added to each well and the cells were incubated for an additional 4h at 37°C, then the formazan precipitate was dissolved in 150 µl of DMSO, and the absorbance at 490 nm was measured using a microplate reader (BioTek Instruments, Inc.). Each test was repeated at least three times.
Apoptosis assays
The apoptotic rates were analyzed by flow cytometry using an annexin V-FITC apoptosis detection kit according to the manufacturer's instructions. Briefly, the cells were seeded in 25cm 2 flask and incubated with indicated drugs for 24 h before the cells were harvested. The cells were concentrated, and washed twice with cold PBS followed by staining with Annexin V-FITC using an assay kit. Data were analyzed using the Bioconsort software (USA). 
Determination of caspase activity
Caspase-3 and caspase-9 activity was determined by colorimetric assay kits (Beyotime Institute of Biotechnology) according to the manufacturer's instructions.
Caspase activity was determined by measuring changes in absorbance at 405 nm using microplate reader (BioTek Instruments, Inc.). All measurements were performed at least 3 times.
Mitochondrial extraction and Western blot analysis
Mitochondrial were extracted using mitochondria isolation kit. Briefly, the 
Statistic analysis
All data are expressed as mean ± SD. SPSS 17.0 software was used to analyze all the data. Statistical analysis was performed using one-way ANOVA followed by Bonferroni's test. p < 0.05 was considered statistically significant.
Results
Esculetin inhibits cell proliferation
To identify the therapeutic potential of esculetin, human SMMC-7721 cells were (Fig. 5) . Further more, western blot analysis showed that the antagonistic action of IGF-1 to esculetin was related with moderate activation of IGF-1/PI3K/Akt pathway (Fig. 6 ). In addition, to further identify the role of Akt in esculetin induced growth inhibition, we employed the inhibitor LY294002 to inhibit
Akt. Combination treatment with esculetin and LY294002 could further enhance the apoptotic effect of esculetin. These results together suggested that pro-apoptotic effects of esculetin were acted with IGF-1/PI3K/Akt pathway related mitochondrial pathway.
Discussion
As a considerably valuable source for novel chemotherapeutic agents, the traditional Chinese medicine products remain one of the best reservoirs of new molecules. Esculetin, one of the traditional Chinese medicine products, has been reported to have potential antitumor activity in various human cancers. In our previous study, we have demonstrated that esculetin could inhibit human hepatic cancer growth both in vito and in vitro, but the underlying mechanism was not well studied. In the present study, we showed that esculetin induces mitochondria-mediated apoptosis in human SMMC-7721 cells, as evidenced by a decrease of mitochondrial potential, increase of bax/bcl-2 expression ratio and cytochrome c translocation from mitochondria to cytosol as well as activation of caspase-3 and caspase-9. In addition, ). In contrast with these, some literatures reported that the baseline mRNA levels of IGF-1 in HCC patients was higher than in normal person (Karabulut et al. 2014) , and the expression of IGF-1R was higher in hepatocellular carcinoma cell lines compared with normal human hepotocytes, and prcropodophyllin, a highly selective inhibitor of IGF-1R, was reported to has pro-apoptotic effect of hepatocellular carcinoma cell through a caspase-depended mitochontrial pathway (E et al. 2013 ). In addition, retrospective study showed that higher IGF-1 expression in adjacent non-neoplastic liver than in tumor, and it was correlated with significantly poorer survival after resection of HCC (Chun et al. 2014) . Anyway, in our present study, we showed that IGF-1 promoted SMMC-7721 cells proliferation, and the pro-apoptotic effect of esculetin was related with down-regulated IGF-1 expression, which was in line with some previous studies. suggested, inflammatory factors such as TNF-α and IL-6 not only contribute to the progression of HCC, TNF-α also promotes insulin resistance by decreasing tyrosine kynase activity of the insulin receptor and consequently reducing insulin activity (Hotamisligil et al. 1996) , TNF-α and interleukin inhibitors have been used for treatment of active ankylosing apondylitis (Betts et al. 2016) . IGF-1 is increased in patients with type 2 diabetes mellitus, the increased IGF-1 is responsible for the developing of cancer, and it has been suggested that non-alcoholic fatty liver disease (NAFLD) as a new criterion to define metabolic syndrome (MetS) (Tarantino and Finelli 2013) , so the effects of esculetin on inflammatory factors and NAFLD should be investigated in the future study.
In summary, the current study demonstrated that esculetin exerts strong antitumor activity in human SMMC-7721 cells with the potential molecular mechanisms of apoptosis induction through IGF-1/PI3K/Akt related mitochondria pathway. Therefore, our study indicates that esculetin might be a promising therapeutic agent against human hepatic cancer.
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